Considering the importance of NRP1 in tumor development and its relevance to RCC1 in a variety of tumors, combined with RCC1 involved in CAF and the tumor infiltration of CD8+ T cells, we believe that RCC1 might be a potential new tumor target involved in the immunosuppressive function of NRP1. Here, CD8A is linked to neoplasm.